Due to the surging geriatric population, the rising incidence of chronic diseases, and the soaring investments being made in research and development (R&D) activities, on account of the increasing government spending on healthcare in various countries, the global pharmaceutical filtration market is set for lucrative growth in the coming years. Furthermore, the rising prevalence of cancer and the booming generic and biopharmaceutical drug production are fueling the market advancement across the globe.
Due to the rising incidence of various chronic diseases and the surging number of initiatives being launched by several government and non-government organizations, the governments of many countries are increasing their healthcare expenditure. According to the World Health Organization (WHO), the increment in the healthcare expenditure is fueling rapid improvements in healthcare infrastructure and augmenting the focus on R&D projects aimed at developing effective pharmaceutical drugs. This is subsequently propelling the progress of the pharmaceutical filtration market.
Amongst these, the membrane filters category recorded the highest growth in the market in the past. This was because of the large-scale usage of membrane filters for pharmaceutical filtration processes, because of the fact that these filters can be easily used in small and large laboratories. Globally, the pharmaceutical filtration market recorded the highest growth in North America in the years gone by. The market registered the highest growth in the U.S. in this region in the past.
Hence, it is safe to say that the market will grow explosively across the world in the future years, on account of the rising incidence of cancer and other chronic diseases and the rising government expenditure on healthcare in several countries around the world.
